Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
Part of paid clinical trials in Fargo, North Dakota.
- Sponsor
- Sanford Health
- Study ID
- NCT06883266
- Status
- Recruiting
Conditions
- Parkinsons Disease (PD)
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- transcranial direct current stimulation (tDCS) — DEVICE2 mA will be administered for 5 consecutive days for a duration of 20 minutes with electrode placement at the left dorsolateral prefrontal cortex.
- Sham (No Treatment) — DEVICEFor 30 seconds, the patient will experience a ramp up of the stimulation, after which point no stimulation will be transmitted for the remainder of the session. This will be administered for 5 consecutive days for a duration of 20 minutes with electrode placement at the left dorsolateral prefrontal cortex
Study Details
The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.
Key Dates
- Start date
- Nov 11, 2024
- Status verified
- Jan 2026
- Primary completion
- Nov 11, 2026
- Completion
- Dec 11, 2026
Study Design
- Enrollment
- 64 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental GroupThe experimental group will receive 2mA of anodal transcranial direct current stimulation (tDCS) for 20 minutes daily for 5 consecutive days.
- Sham Comparator: Sham GroupThe sham group will be connected to the anodal transcranial direct current stimulation device daily for 5 days. During the 20 minute sessions, the participant will only receive stimulation for a 30-second ramp up period, at which point the stimulation will be discontinued for the remainder of the time.
Primary Outcome Measure
Finger and Toe-Tapping on KinesiaOne Device [ Time Frame: 30 minutes; pre-test during the second research visit, post-test on 6th research visit after 5 consecutive days of tDCS, a follow up test on the 7th research visit, 7 days after last tDCS session and 8th visit 14 days after last tDCS session ]
Central Contacts
- Jessica Keller, B.S.701-417-5781
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sanford Brain and Spine Center | Fargo | North Dakota | 58103 | Jau-Shin Lou, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Fargo, ND
By research site
Related Studies
- A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePHASE3 · Recruiting · BlueRock Therapeutics · Sun City, Arizona
- TMS in Anxiety-Parkinson's DiseaseEnrolling By Invitation · HealthPartners Institute · Saint Paul, Minnesota
- Neuroimaging of Parkinson'sRecruiting · Washington University School of Medicine · St Louis, Missouri
- Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.PHASE1 · Recruiting · Pravat Mandal · Pittsburgh, Pennsylvania